Menu
Hepatitis latest research
In response to the World Health Organization's current focus on treating hepatitis and reducing infections worldwide, Dove Medical Press has compiled the latest research on hepatitis and hepatocellular carcinoma across our portfolio of journals. Thank you to our community of authors and peer reviewers who continue to contribute to the campaign against this disease.
This content is free to access and updated daily.
- 276 records -
Comparison of Clinical Manifestations and Related Factors of Hepatocellular Carcinoma with Chronic Hepatitis B
Hou H, Liang L, Deng L, Ye W, Wen Y, Liu J
International Journal of General Medicine 2024, 17:2877-2886
Published Date: 25 June 2024
The Influence of Visceral Adiposity on Overall Survival: Exploring “Obesity Paradox” Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy
Zhou Y, Ouyang J, Yang H, Wang Z, Yang Y, Li Q, Zhao H, Zhou J, Li Q
Journal of Hepatocellular Carcinoma 2024, 11:1193-1206
Published Date: 24 June 2024
PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective Study
Wang D, Zhang Z, Yang L, Zhao L, Liu Z, Lou C
Journal of Hepatocellular Carcinoma 2024, 11:1157-1170
Published Date: 18 June 2024
Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study
Liu X, Qiu Z, Ndhlovu E, Wan Y, Sun H, Wang S, Cao Y, Zhu P
Journal of Hepatocellular Carcinoma 2024, 11:1127-1141
Published Date: 14 June 2024
Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis
Feng Y, Liang L, Jia W, Wang J, Xu C, Zhu D, Xu B, Zhao W, Ling X, Zhou Y, Kong L, Ding W
Journal of Hepatocellular Carcinoma 2024, 11:1095-1112
Published Date: 13 June 2024
Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study
Zheng Y, Xiang Y, Shi H, Lin Z, Cheng S, Zhu J
Journal of Hepatocellular Carcinoma 2024, 11:1079-1093
Published Date: 12 June 2024
Efficacy and Safety of Transarterial Chemoembolization and Repeated Partial Splenic Embolization for Hepatocellular Carcinoma with Hypersplenism and Thrombocytopenia
Hong W, Wang Z, Yao W, Zhang X, Zhang L, Liang B
Journal of Hepatocellular Carcinoma 2024, 11:1065-1078
Published Date: 11 June 2024
Real-World Effectiveness of First Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current Insights
Biachi de Castria T, Kim RD
Pragmatic and Observational Research 2024, 15:79-87
Published Date: 10 June 2024
Development and Validation of a Novel Prognostic Nomogram Based on Platelet and CD8+T Cell Counts in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
Shi W, Yan H, Liu X, Yu L, Xie Y, Wu Y, Liang Y, Yang Z
Journal of Hepatocellular Carcinoma 2024, 11:1049-1063
Published Date: 7 June 2024
Impact of HBV Integration on Hepatocellular Carcinoma After Long-Term Antiviral Therapy
Wang H, Hu B, Liang H, Wang R, Wei L, Su T, Li Q, Yin Q, Feng Y, Su M, Jiang J
International Journal of General Medicine 2024, 17:2643-2653
Published Date: 6 June 2024
LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma
Xiao S, Lu L, Lin Z, Ye X, Su S, Zhang C, You Y, Li W, Huang X, Wu W, Zhou Y
Journal of Hepatocellular Carcinoma 2024, 11:1031-1048
Published Date: 6 June 2024
Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance Perspective
Schwander B, Klesper K, Rossol S, Herrmann K, Zoellner YF
ClinicoEconomics and Outcomes Research 2024, 16:483-492
Published Date: 6 June 2024
Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma
Chen BB, Liang PC, Shih TTF, Liu TH, Shen YC, Lu LC, Lin ZZ, Hsu C, Hsu CH, Cheng AL, Shao YY
Journal of Hepatocellular Carcinoma 2024, 11:1015-1029
Published Date: 5 June 2024
A Comparison of Presentation, Treatment, and Survival After Hepatocellular Carcinoma of Viral and Non-Viral Etiology in Damietta, Egypt, 2007–2019
Jean K, Tawheed A, Luong Nguyen LB, Heikal T, Eldaly U, Elhadidy NG, Elghaieb A, Aboudonia A, Tondeur L, Dublineau A, Fontanet A, El-Kassas M
Journal of Hepatocellular Carcinoma 2024, 11:997-1004
Published Date: 31 May 2024
A Post-International Gastrointestinal Cancers’ Conference (IGICC) Position Statements
Yalcin S, Lacin S, Kaseb AO, Peynircioğlu B, Cantasdemir M, Çil BE, Hurmuz P, Doğrul AB, Bozkurt MF, Abali H, Akhan O, Şimşek H, Sahin B, Aykan FN, Yücel İ, Tellioğlu G, Selçukbiricik F, Philip PA
Journal of Hepatocellular Carcinoma 2024, 11:953-974
Published Date: 29 May 2024
The Correlation of Centromere Protein Q with Diagnosis and Prognosis in Hepatocellular Carcinoma
He K, Xie MY, Gao XJ, Wang H, Li JD
Pharmacogenomics and Personalized Medicine 2024, 17:271-288
Published Date: 27 May 2024
Preoperative Antiviral Therapy and Long-Term Outcomes for Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Liver Resection: A Multicenter Analysis
Dai MG, Liu SY, Zhu L, Lu WF, Xie GL, Liang L, Liu JW, Ye B
Journal of Hepatocellular Carcinoma 2024, 11:927-939
Published Date: 23 May 2024
LARS1 is a Prognostic Biomarker and Exhibits a Correlation with Immune Infiltrates in Hepatocellular Carcinoma
Fan L, Qin Z, Wu D, Yang Y, Zhang Y, Xie B, Qian J, Wei J, Wang Z, Yang P, Qian Z, Yuan M, Zhu Z, Tan Y, Tan Y
International Journal of General Medicine 2024, 17:2203-2221
Published Date: 17 May 2024
A Novel Nomogram to Predict Prognosis in Elderly Early-Stage Hepatocellular Carcinoma Patients After Ablation Therapy
Tang X, Wang Q, Jin R, Hu C
Journal of Hepatocellular Carcinoma 2024, 11:901-911
Published Date: 17 May 2024
Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing to Identify an Immunogenic Cell Death-Related 5-Gene Prognostic Signature in Hepatocellular Carcinoma
Peng L, Xu S, Xu JL
Journal of Hepatocellular Carcinoma 2024, 11:879-900
Published Date: 16 May 2024
Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for Hepatocellular Carcinoma with Extrahepatic Metastasis
Duan WB, Wang XH, Zhang GC, He Z, Li SQ, Zhou J
ImmunoTargets and Therapy 2024, 13:247-258
Published Date: 16 May 2024
Construction of a Prognostic Model for Hepatocellular Carcinoma Based on Macrophage Polarization-Related Genes
Chen H, Li J, Cao D, Tang H
Journal of Hepatocellular Carcinoma 2024, 11:857-878
Published Date: 11 May 2024
PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration
Gong Y, Zhou M, Zhu Y, Pan J, Zhou X, Jiang Y, Zeng H, Zheng H, Geng X, Huang D
Journal of Hepatocellular Carcinoma 2024, 11:813-838
Published Date: 8 May 2024
Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion
Yu Y, Wang XH, Hu WJ, Chen DH, Hu ZL, Li SQ
Journal of Hepatocellular Carcinoma 2024, 11:801-812
Published Date: 8 May 2024
Understanding Gene Involvement in Hepatocellular Carcinoma: Implications for Gene Therapy and Personalized Medicine
Younis MA, Harashima H
Pharmacogenomics and Personalized Medicine 2024, 17:193-213
Published Date: 7 May 2024
Negative Impact of Intra-Operative Blood Transfusion on Survival Outcomes of Hepatocellular Carcinoma Patients
Teng L, Zhao L, Shao H, Dai J, Zou H
Cancer Management and Research 2024, 16:385-393
Published Date: 25 April 2024
Clinical Characteristics of Non-B and Non-C Biopsy-Proven Primary Liver Cancers in an HBV- Endemic Area: A Retrospective Study
Hu Z, Zhou H
Journal of Hepatocellular Carcinoma 2024, 11:767-774
Published Date: 24 April 2024
A Novel Four-Gene Signature Based on Nonsense-Mediated RNA Decay for Predicting Prognosis in Hepatocellular Carcinoma: Bioinformatics Analysis and Functional Validation
Zhao J, Wang C, Zhao L, Zhou H, Wu R, Zhang T, Ding J, Zhou J, Zheng H, Zhang L, Kong T, Zhou J, Hu Z
Journal of Hepatocellular Carcinoma 2024, 11:747-766
Published Date: 23 April 2024
Construction of an Immunogenic Cell Death-Related Gene Signature and Genetic Subtypes for Predicting Prognosis, Immune Microenvironments, and Drug Sensitivity in Hepatocellular Carcinoma
Li S, Zhang T, Sun X, Li X
Journal of Inflammation Research 2024, 17:2427-2444
Published Date: 22 April 2024
Synchronous Double Primary Tumors of Liver (Small Cell Neuroendocrine Carcinoma and Hepatocellular carcinoma): A Case Report
Bu Y, Wen J, Wang F, Dong S, He L, Li Y, Liang J, Zhang H
Hepatic Medicine: Evidence and Research 2024, 16:31-36
Published Date: 20 April 2024
Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis
Yang SH, He YS, Zheng SQ, Zhang XJ, Dai H, Xue Y
Journal of Hepatocellular Carcinoma 2024, 11:737-746
Published Date: 18 April 2024
Adjuvant Transarterial Chemoembolization Plus Immunotherapy for Huge Hepatocellular Carcinoma: A Propensity Score Matching Cohort Study
Huang H, Liao W, Zhang K, Wang H, Cheng Q, Mei B
Journal of Hepatocellular Carcinoma 2024, 11:721-735
Published Date: 8 April 2024
Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy
Xie D, Li Z, Yuan J, Yin X, Chen R, Zhang L, Ren Z
Journal of Hepatocellular Carcinoma 2024, 11:693-705
Published Date: 4 April 2024
High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization
Zhang B, Huang B, Yang F, Yang J, Kong M, Wang J, Xiang Y, Wang K, Peng R, Yang K, An C, Yan D
Journal of Hepatocellular Carcinoma 2024, 11:651-663
Published Date: 27 March 2024
Induction of Hepatocellular Carcinoma in Conventional Domestic Swine Using N-Diethylnitrosamine and Phenobarbital
Giselvania A, Juniantito V, Wibowo H, Siregar TP, Gondhowiardjo S
Cancer Management and Research 2024, 16:245-257
Published Date: 25 March 2024
The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients
Ma X, Sun X, Xie F, Jian W, Wang Q, Xie Y, Li C, Zhang K
Journal of Hepatocellular Carcinoma 2024, 11:619-628
Published Date: 25 March 2024
Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro
Du YQ, Yuan B, Ye YX, Zhou FL, Liu H, Huang JJ, Wei YF
Journal of Hepatocellular Carcinoma 2024, 11:565-580
Published Date: 19 March 2024
Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
Chen P, Li Y, Dai Y, Wang Z, Zhou Y, Wang Y, Li G
Journal of Hepatocellular Carcinoma 2024, 11:581-594
Published Date: 19 March 2024
Efficacy and Safety of Hepatic Arterial Infusion Therapy with Cinobufacini in Advanced Hepatocellular Carcinoma with Macrovascular Invasion: A Retrospective Cohort Study
Xue T, Yu H, Feng W, Wang Y, Wu S, Wang L, Zhu P, Guan J, Sun Q
Cancer Management and Research 2024, 16:163-175
Published Date: 14 March 2024
A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
Zong S, Huang G, Pan B, Zhao S, Ling C, Cheng B
Journal of Hepatocellular Carcinoma 2024, 11:525-542
Published Date: 12 March 2024
LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma
Wei H, Wu X, Huang L, Long C, Lu Q, Huang Z, Huang Y, Li W, Pu J
Journal of Hepatocellular Carcinoma 2024, 11:543-562
Published Date: 11 March 2024
Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation
Shan L, Zhao N, Wang F, Zhai D, Liu J, Lv X
Journal of Inflammation Research 2024, 17:1589-1605
Published Date: 11 March 2024
Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative Liver Function-Nutrition-Inflammation-Immune (LFNII) Score: A Bicentric Investigation
Zhang BL, Liu J, Diao G, Chang J, Xue J, Huang Z, Zhao H, Yu L, Cai J
Journal of Hepatocellular Carcinoma 2024, 11:489-508
Published Date: 6 March 2024
A Deep Learning Model Combining Multimodal Factors to Predict the Overall Survival of Transarterial Chemoembolization
Sun Z, Li X, Liang H, Shi Z, Ren H
Journal of Hepatocellular Carcinoma 2024, 11:385-397
Published Date: 26 February 2024
Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1+ Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment
Liang Y, Zhong D, Yang Q, Tang Y, Qin Y, Su Y, Huang X, Shang J
Journal of Hepatocellular Carcinoma 2024, 11:373-383
Published Date: 22 February 2024
Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?
Himmelsbach V, Koch C, Trojan J, Finkelmeier F
Journal of Hepatocellular Carcinoma 2024, 11:363-372
Published Date: 19 February 2024
Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia
Alolyan A, Alshammari K, Arabi M, Alshehri A, Alsuhaibani H, Ibnshamsah F, Alsharm A, Mahrous M, Al Zanbagi A, Hassanain M, Bazarbashi S
Journal of Hepatocellular Carcinoma 2024, 11:349-362
Published Date: 16 February 2024
Lipid Metabolism as a Potential Target of Liver Cancer
Wu K, Lin F
Journal of Hepatocellular Carcinoma 2024, 11:327-346
Published Date: 14 February 2024
C-Reactive Protein-Albumin Ratio (CAR): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Curative Hepatectomy for Hepatocellular Carcinoma
Mai RY, Lu TL, Lu RJ, Zeng C, Lian F, Li LQ, Wu GB, Ye JZ
Journal of Inflammation Research 2024, 17:919-931
Published Date: 12 February 2024
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy
Shi Z, Zhu S, Jin Y, Qi L, Zhou M, Zhou Z, Zhang J, Liu B, Shen J
Journal of Hepatocellular Carcinoma 2024, 11:305-316
Published Date: 8 February 2024